Order Article Reprints

Luna-Nophal A, Díaz-Castillo F, Izquierdo-Sánchez V, Velázquez-Fernández JB, Orozco-Morales M, Lara-Mejía L, Bernáldez-Sarabia J, Sánchez-Campos N, Arrieta O, Díaz-Chávez J, et al. Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma. Marine Drugs. 2025; 23(1):32. https://doi.org/10.3390/md23010032

Luna-Nophal, Angélica, Fernando Díaz-Castillo, Vanessa Izquierdo-Sánchez, Jesús B. Velázquez-Fernández, Mario Orozco-Morales, Luis Lara-Mejía, Johana Bernáldez-Sarabia, Noemí Sánchez-Campos, Oscar Arrieta, José Díaz-Chávez, and et al. 2025. "Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma" Marine Drugs 23, no. 1: 32. https://doi.org/10.3390/md23010032

Luna-Nophal, A., Díaz-Castillo, F., Izquierdo-Sánchez, V., Velázquez-Fernández, J. B., Orozco-Morales, M., Lara-Mejía, L., Bernáldez-Sarabia, J., Sánchez-Campos, N., Arrieta, O., Díaz-Chávez, J., Castañeda-Sánchez, J.-I., Licea-Navarro, A.-F., & Muñiz-Hernández, S. (2025). Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma. Marine Drugs, 23(1), 32. https://doi.org/10.3390/md23010032